- This event has passed.
Safety of Stem Cell – Derived Therapies: Trends and Future Technologies
07/10/2019 - 08/10/2019
Registration: OPEN (deadline 27 September 2019)
Abstract submission: OPEN (deadline 06 September 2019)
Stem cell-derived therapies are complex and diverse, so it is critical that we understand the challenges faced in getting clinical trials for these therapies approved.
Across two days, we will discuss how some therapies have made progress towards clinical trials, particularly in relation to assessing safety. We will also look at areas where new technologies can fill vital gaps, such as in combination therapies with smart materials.
This meeting will be of particular interest to pharmacologists, those working in toxicology, clinicians, academics and industry. Regulators, including MHRA and FDA, will also be joining our panel discussions.
Hear from leaders in the field including Pete Coffey, Agnete Kirkeby, Martin Pera, Kevin Eggan, David Hay, Richard Adair, Sarah Waters and our key note speaker, Jane Lebkowski.
CPD points from the Royal College of Physicians and Royal Society of Biology are available at this meeting. You will be emailed a certificate of attendance with CPD points after the meeting.
Submit an abstract
Poster presentations are available at this meeting. Please submit an abstract for the meeting before the deadline, 06 September 2019.
Please refer to our abstract guidelines for authors for more information on submitting an abstract for the meeting.
If you have any questions about the abstract submission process please email firstname.lastname@example.org